[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100488928":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":34,"responsibleParty":53,"collaborators":56,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":18,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":18,"enrollmentInfo":72,"targetDuration":18,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":18,"overallStatus":36,"whyStopped":18,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"University of Texas Southwestern Medical Center","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"BCa Early Screening Group","EXPERIMENTAL","All participants undergo Urinalysis testing every 6 months for 2 years. Based on the RBC count, each participant will go through each of the screening procedures : \\[cystoscopy + Upper tract imaging\\] or \\[urine marker cancer testing with Cxbladder triage + Upper tract imaging\\] or \\[Repeat urinalysis\\]\n\nPatients with suspicious findings on cystoscopy or imaging will get treatment as per standard of care.\n\nTheir outcomes will be compared to a historical control (bladder cancer detected by standard of care using SEER registries).",[13],"Diagnostic Test: Urinalysis",{"label":15,"type":16,"description":17,"interventionNames":18},"Historical Control Group","NO_INTERVENTION","This will include historical control (bladder cancer detected in patients by standard of care) using SEER registries).",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"DIAGNOSTIC_TEST","Urinalysis","Urine analysis (every 6 months for 2 years); Patients with \\\u003C3 red blood cells (RBCs) per high-powered field (HPF) will repeat screening at 6-month intervals for an average of 2 years.\n\nIf RBCs are 3-25 RBSc\u002FHPF- subjects will undergo- \\[cystoscopy + Upper tract imaging\\] or \\[urine marker cancer testing with Cxbladder triage + Upper tract imaging\\].\n\nIf \\>25 RBCs, subjects will get - \\[cystoscopy + Upper tract imaging\\].",[9],[26],{"name":27,"affiliation":5,"role":28},"Yair Lotan, MD","PRINCIPAL_INVESTIGATOR",[30],{"name":27,"role":31,"phone":32,"phoneExt":18,"email":33},"CONTACT","214-648-0389","yair.lotan@UTsouthwestern.edu",[35],{"facility":5,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RECRUITING","Dallas","Texas","75390","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-96.80667,32.78306,{"lat":46,"lon":45},[49,52],{"name":50,"role":31,"phone":51,"phoneExt":18,"email":18},"Sonobia Garrett","214-645-8787",{"name":27,"role":28,"phone":18,"phoneExt":18,"email":18},{"type":28,"investigatorFullName":54,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"yair lotan","Professor-Urology",[57,60],{"name":58,"class":59},"Wilson Charitable Foundation Trust","UNKNOWN",{"name":61,"class":62},"Pacific Edge Limited","INDUSTRY","100488928","bladder-cancer-screening-trial-100488928",false,"NCT05646485","Bladder Cancer Screening Trial","Optimal Screening Strategy for Bladder Cancer in at Risk Patients","Inclusion Criteria:\n\n* Age ≥ 50\n* Smoking: ≥15 pack-year smoking history\n* Occupation:≥ 15 years of occupational exposures including: textile worker, painter, dry cleaners\n\nExclusion Criteria:\n\n* Prior history of bladder, kidney, or prostate cancer\n* Prior evaluation of micro or gross hematuria within the last 2 years\n* Do not provide informed consent","ALL","50 Years",{"count":73,"type":74},1000,"ESTIMATED","INTERVENTIONAL",[77],"NA","There is currently no accepted screening strategy for patients at high risk of developing bladder cancer. This study will ask patients to complete a urine test every 6 months for 2 years to help assess if routine screening helps finding bladder cancer at an earlier stage.",[80,81,82,83],"Bladder Cancer","Urothelial Carcinoma","Hematuria","Smoking Cessation","2026-04-27",{"date":86,"type":87},"2026-05-01","ACTUAL",{"date":89,"type":87},"2023-05-05",{"date":91,"type":74},"2028-04",{"name":5,"class":6},1]